Clinical Trial Update: Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of sildenafil in children with pulmonary arterial hypertension has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension, Hypertension, Pulmonary | Phase 4 | Status: COMPLETED | Results posted: 2017-04-04